SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer

NCT00002651 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

3040

Enrollment

NETWORK

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: bicalutamide
DRUG: goserelin acetate
OTHER: clinical observation

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]